The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of germline homologous recombination deficiency mutations with HER2 status conversion from negative to positive following neoadjuvant chemotherapy in breast cancer.
 
Colin Bergstrom
No Relationships to Disclose
 
Megan Troxell
No Relationships to Disclose
 
Jennifer Caswell-Jin
Consulting or Advisory Role - Citizen Health (I)
Research Funding - eFFECTOR Therapeutics (Inst); Novartis (Inst); QED Therapeutics (Inst)
 
Gregory Bean
No Relationships to Disclose
 
Kimberly Allison
No Relationships to Disclose
 
Melinda Telli
Consulting or Advisory Role - Arvinas; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Foresight Diagnostics; G1 Therapeutics; Genentech/Roche; Gilead Sciences; GlaxoSmithKline; Merck; Natera; Summit Therapeutics
Research Funding - Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); BioNTech SE (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Hummingbird (Inst); Merck (Inst); Pfizer (Inst)
Other Relationship - G1 Therapeutics